Sanket Koul

Centre proposes easing shelf-life, licensing norms for imported drugs

Draft amendments propose a 12-month minimum residual shelf life for imported drugs and an acknowledgement-based mechanism for importing medicines for research

Centre scraps Jackson Labs' licences amid Rajasthan maternal deaths probe

WHO has sought additional information after reports linked suspected fake oxytocin injections to maternal deaths in Rajasthan, while the Centre cancelled the firm's licences

Eli Lilly launches its first solid tumour RET-gene therapy in India

The US drugmaker has launched Tanstrive, a RET-targeted oral therapy for advanced or metastatic solid tumours, following marketing authorisation from the CDSCO

Hero MotoCorp, WeWork lease 3.5 lakh sq ft in Worldmark for ₹922 crore

Hero MotoCorp and WeWork have signed separate long-term office leases at Bharti Real Estate's Worldmark complex in Aerocity, with a combined rental outlay of about Rs 922 crore

Centre brings vaccines, anti-cancer drugs under QR code tracking regime

The Health Ministry will expand mandatory QR code-based traceability to vaccines, antimicrobials, anti-cancer, narcotic and psychotropic drugs in a phased rollout

Submit quarterly data on essential medicines: NPPA tells drugmakers

The drug pricing regulator has directed manufacturers to regularly furnish production and sales data for scheduled formulations to strengthen monitoring of essential medicines

Manglam Group ties up with Marriott for ₹350 crore Sheraton hotel in Jaipur

The 220-key luxury hotel on the Jaipur-Ajmer Highway is part of Manglam Group's broader Rs 1,000 crore hospitality investment plan over five years

National developers expand footprint in Delhi-NCR housing market

Share of national developers in Delhi-NCR's residential supply has risen from 3 per cent in 2022 to over 13 per cent, driven by premium housing demand and infrastructure growth

Centre mandates periodic renewal of IVF, ART and surrogacy clinics

Centre mandates periodic renewal of registrations for ART and surrogacy clinics to strengthen oversight, improve compliance, and boost patient confidence

Accenture leases 1 mn sq ft office space in Hyderabad for over ₹1,000 crore

The company has also deposited Rs 29.5 crore as security, with the lease including a 4.25 per cent rent escalation every year

Centre seeks stakeholder views on medical devices exempt from GTE norms

Department of Pharmaceuticals invites stakeholder comments on proposed additions and deletions to the list of medical devices exempted from Global Trade Enquiry requirements

Smartworks renews lease for 2.3 lakh sq ft office space in Hyderabad

Co-working and flex-space provider commits Rs 121 crore over five years for Hyderabad office space as it pursues expansion across key urban and Tier-I markets

Government bans 16 fixed drug combinations over health safety concerns

Health Ministry prohibits 16 fixed drug combinations, including antibiotic and cosmetic formulations, after an expert review found they lacked therapeutic justification and posed potential health risk

CDSCO prohibits clinical trials at KKR-backed HCG cancer hospital

Drug regulator alleges irregularities in reporting adverse events and conflict-of-interest disclosures by the unit's ethics committee during human clinical trials

Namo Cities: Delhi's decongestion dream faces the test of execution

Experts flag coordination gaps as Centre bets on transit-led satellite hubs

Target India signs ₹1,250-crore Bengaluru office lease for GCC expansion

The retailer's India arm has leased 8.3 lakh sq ft at Embassy Manyata Business Park, reinforcing Bengaluru's position as the leading hub for GCC-led office demand

Tulip Infratech plans ₹6,000 crore investment in Gurugram luxury housing

Developer launches Rs 1,100-crore Tulip Melrose project on Southern Peripheral Road as part of a larger luxury housing expansion plan

Govt's cough syrup move may shift rural demand towards Ayush remedies

The removal of cough syrups from Schedule K could make access more prescription-dependent in rural India, potentially shifting some demand towards Ayush products

Mumbai-based investor buys apartment in The Dahlias for ₹120 crore

The acquisition adds to a series of high-value transactions at DLF's super-luxury Gurugram project, where prices have risen sharply since launch

Maha FDA: Hospitals can't force patients to buy drugs from own pharmacies

The state regulator has directed hospitals and doctors to provide prescriptions directly to patients and allow them to buy medicines from any licensed pharmacy